Remember meForgot password?
    Log in with Twitter

biosimilars News

Big growth projected in biosimilars drug market

Over the course of just five years, the global market in biosimilar medicines has risen to over $5 billion. Biosimilars are complex drugs identical to a branded one, but manufactured by a different company.

Government of British Columbia expands biosimilar medicines

The Government of British Columbia has announced a program in which patients taking originator biologic drugs will be "switched" or transitioned by their clinicians to a biosimilar biologic drug within a six-month period.

U.S. approves first biosimilar medicinal product

The U.S. Food and Drug Administration (FDA) has approved pharma company Sandoz’s drug Zarxio. This is a biosimilar to Amgen’s filgrastim, which is mainly prescribed for cancer patients.

Search Digital Journal Archives

Set up a news alert for


biosimilars Image

Latest News
Top News